Events

Vergangene Events

24. Juni 2026
3:00 p.m. - 4:00 p.m.

One Health Seminar: From Outbreak to Containment ‒ Understanding Ebola viruses and the Current Bundibugyo Ebolavirus Outbreak

Jil Alexandra Haase

Jil Alexandra Haase, Dr. rer. nat., is a post-doctoral researcher at the Immunology and Molecular Virology Section, in the Laboratory for Virology, Division of Intramural Research, National Institute for Allergy and Infectious Diseases at the National Institutes of Health, USA (Marzi Research Group | NIAID: National Institute of Allergy and Infectious Diseases).
10. Juni 2026
2:00 p.m. - 3:15 p.m.

Speeding up vaccine design and antibody discovery using cryoEM and AI/ML

Andrew Ward

Medical University of Vienna

Jugendstilhörsaal

Spitalgasse 23

1090 Vienna

One of the rate-limiting steps in analyzing immune responses to vaccines or infections is the isolation and characterization of monoclonal antibodies.
27. Mai 2026
3:00 p.m. - 4:00 p.m.

One Health Seminar: Clinical aspects of Hantavirus Infections

Robert Krause

Hantaviruses are the etiological agent of hemorrhagic fever with renal syndrome (HFRS) and hantavirus cardiopulmonary syndrome (HCPS).
13. Mai 2026
2:00 p.m. - 3:15 p.m.

Analysis of protective immunity to Mycobacterium tuberculosis in exposed household contacts from The Gambia

Jayne Sutherland

Medical University of Vienna

Jugendstilhörsaal

Spitalgasse 23

1090 Vienna

Tuberculosis remains the leading cause of death from a single pathogen with over one million deaths per year.
29. April 2026
3:00 p.m. - 4:00 p.m.

One Health Seminar: Influenza viruses at the Human-Animal Interface, a WHO Collaborating Centre perspective

Alexander Byrne

Influenza viruses at the Human-Animal Interface, a WHO Collaborating Centre perspective
15. April 2026
2:00 p.m. - 3:15 p.m.

From Innovation to Impact: MVA Vaccines in Viral Disease Prevention and Therapy

Marylyn M. Addo

Johannes Kepler Universität Linz

Altenberger Straße 69

4040 Linz

1. April 2026
3:00 p.m. - 4:00 p.m.

One Health Seminar: Mapping the Zoonotic Web: A network-based approach to One Health

Amélie Desvars-Larivve

4. März 2026
3:00 p.m. - 4:00 p.m.

One Health Seminar: Let’s Talk About Sex (Hormones) and Emerging Viruses 

Angela Rasmussen

Let’s Talk About Sex (Hormones) and Emerging Viruses
18. Februar 2026
2:00 p.m. - 3:15 p.m.

Decoding Pandemic Influenza Viruses

Martin Schwemmle

CeMM Forschungszentrum für Molekulare Medizin GmbH
8. Stock

Influenza A viruses (IAVs) primarily circulate in wild waterfowl but can occasionally spread to other species, including humans.
4. Februar 2026
7:00 p.m. - 8:00 p.m.

One Health Seminar: Highly pathogenic avian influenza in Antarctica

Michelle Wille

Dr. Michelle Wille is the outreach coordinator at the WHO Collaborating Centre for Reference and Research on Influenza and a senior researcher at the University of Melbourne.
21. Januar 2026
2:00 p.m. - 3:30 p.m.

Understanding how respiratory viruses cause pandemics

Wendy Barclay

Medical University of Vienna

Jugendstilhörsaal

Spitalgasse 23

1090 Vienna

Respiratory virus pandemics bring high morbidity and mortality and significant social disruption.
7. Januar 2026
3:00 p.m. - 4:00 p.m.

One Health Seminar: HPAIV H5N1 – How Bird Flu Became a Global Threat

Martin Beer

HPAIV H5N1 – How Bird Flu Became a Global Threat
10. Dezember 2025
3:00 p.m. - 4:00 p.m.

One Health Seminar: Tularemia – an important Zoonosis in Austria

Alexander Indra & Zoltan Bago

Francisella tularensis, the bacterium responsible for tularemia (also known as “rabbit fever”), is a zoonotic pathogen that has garnered increased public health attention in recent years due to rising case numbers.
26. November 2025
2:00 p.m. - 3:30 a.m.

Respiratory IgA and Protection against Infection: Insights from Longitudinal Surveillance in a Swedish Healthcare Worker Cohort

Charlotte Thålin

CeMM Forschungszentrum für Molekulare Medizin GmbH
8. Stock

Respiratory viruses such as corona-, influenza- and respiratory syncytial viruses initiate infection at mucosal surfaces of the respiratory tract. Yet, current vaccines primarily elicit systemic immunity, with limited induction of mucosal antibodies and a limited protection against respiratory infections.
12. November 2025
3:00 p.m. - 4:00 p.m.

One Health in Public Health: Examples from the New York City Health Department

Sally Slavinski

The NYC Health Department sits at the intersection of environmental, human and animal health, and strives to embody One Health through strong partnerships between animal health professionals and public health.
17. September 2025
3:00 p.m. - 4:00 p.m.

Wie kann One Health uns helfen, Pandemien zu verhindern?

Peter Daszak

Online

LBI SOAP’s One Health Seminar Series
21. August 2025
9:00 a.m. - 11:30 a.m.

Quantifying Specific Correlates of Protection for Respiratory Viral Infections

Paul Thomas

Medical University of Vienna

Jugendstilhörsaal

Spitalgasse 23

1090 Vienna

TCR sequencing enables robust and specific analysis of T cell–mediated protection, overcoming assay complexity and HLA diversity to inform vaccine design.
20. August 2025
9:00 a.m. - 11:30 a.m.

Redefining Virus Evolution and Emergence Using Metatranscriptomics

Edward Holmes

Medical University of Vienna

Jugendstilhörsaal

Rektoratsgebäude BT88

Spitalgasse 23

1090 Vienna

Metatranscriptomics combined with AI reveals unprecedented RNA virus diversity, uncovering highly divergent viruses across ecosystems and redefining the virosphere.
23. April 2025
8:30 a.m. - 5:45 p.m.

From Emerging Pathogens to Vaccines and Therapeutics

Scientific kick-off symposium for the Ignaz Semmelweis Institute

Hörsaalzentrum der MedUni Wen im AKH Wien
Hörsaal 3, Ebene 07

We invite you to participate in the upcoming symposium, „From Emerging Pathogens to Vaccines and Therapeutics“, which is the scientific kick-off symposium for the Ignaz Semmelweis Institute and will bring together internationally renowned researchers and clinicians to discuss current advances and challenges in infectious disease research and biomedical innovation.
21. November 2024
9:00 a.m. - 12:00 p.m.

Charakterisierung der Keimzentrum-B-Zell-Reaktion auf SARS-CoV-2 und Influenza Impfung beim Menschens

Ali Ellebedy

Medizinische Universität Wien
Jugendstil Hörsaal
Rektoratsgebäude BT88
Spitalgasse 23
1090 Wien

Nach einer Impfung können sich die antwortenden B-Zellen entweder über den extrafollikulären Weg differenzieren, was zur Bildung von kurzlebigen Plasmablasten führt, oder über den Weg des Keimzentrums (germinal center, GC) in Lymphknoten, was zur Bildung von langlebigen Plasmazellen und Gedächtnis-B-Zellen führt.